Table 5 Incidence of TEAEs Associated With Discontinuation
| Â | Placebo (n = 62) | 30 mg/d LDX (n = 119) | 50 mg/d LDX (n = 117) | 70 mg/d LDX (n = 122) | Active Doses (n = 358) |
|---|---|---|---|---|---|
Discontinuation, n (%) | Â | Â | Â | Â | Â |
   Insomnia | 0 (0) | 2 (1.7) | 3 (2.6) | 3 (2.5) | 8 (2.2) |
   Sleep disorder | 0 (0) | 0 (0) | 1 (0.9) | 0 (0) | 1 (0.3) |
   Hypersomnia | 0 (0) | 1 (0.8) | 0 (0) | 0 (0) | 1 (0.3) |